Physician profile
Christopher Smith
NPI 1386734101
$3,664.90
in general payments reported to CMS, 2019-2025
17 companies · $839 in 2025
The $839 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $120 · 2021: $30.93 · 2022: $552 · 2023: $626 · 2024: $990 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,387 · Education: $67.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.06 |
| Education | $67.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,787.95 | 2022-2025 | Endurant Iis, Heli-Fx Endoanchor System, Hawkone |
| Silk Road Medical, INC. | $623.48 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bard Peripheral Vascular, INC. | $427.55 | 2019 | |
| Medtronic Vascular, INC. | $170.33 | 2019-2020 | |
| Endologix LLC | $146.43 | 2025 | |
| Merck Sharp & Dohme LLC | $115.07 | 2021-2025 | Verquvo, Vaxneuvance, Gardasil 9 |
| Abbott Laboratories | $105.25 | 2024 | Cardiomems |
| Boston Scientific Corporation | $55.56 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Eluvia |
| Surmodics, INC. | $43.01 | 2022 | |
| Pfizer INC. | $41.36 | 2021-2023 | |
| Inari Medical, INC. | $28.56 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Organogenesis INC. | $24.33 | 2023 | Puraply |
| Csl Behring | $24.31 | 2022 | |
| Penumbra, INC. | $22.39 | 2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $18.24 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $17.75 | 2024 | Hydro Lemaitre Valvulotome |
| Ethicon US, LLC | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.